A phase II study of the Ras-MAPK signaling pathway inhibitor TLN-4601 in patients with glioblastoma at first progression.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Annick Desjardins David Mathieu Q111384291 Antonio Omuro |
| Publication date | November 3, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |